Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
March 05, 2024 16:45 ET
|
Prelude Therapeutics, Inc.
Prelude Therapeutics to present preclinical data posters at the 2024 AACR on its oral SMARCA2 degrader, CDK9 inhibitor and next-gen CDK4/6 inhibitor
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
February 15, 2024 16:05 ET
|
Prelude Therapeutics, Inc.
First-in-class IV SMARCA2 degrader and potentially best-in-class CDK9 inhibitor on track to generate potential proof-of-concept data in 2024 Highly selective oral SMARCA2 degrader PRT7732 IND...
X5 Music Group, Fidelio Music, Pierian Recording Society, and Prelude Records Join the Naxos of America Distribution Family
October 04, 2011 16:48 ET
|
Naxos of America, Inc.
FRANKLIN, TN--(Marketwire - Oct 4, 2011) - Founded in Stockholm, Sweden in 2003, X5 Music (http://www.x5musicgroup.com/) has become Europe's leading digital music label. By licensing and acquiring...